Drugs / Fluad H5N1 Pandemic Influenza Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00478816 Comparator | May 2007 → Feb 2009 | avian influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluad H5N1 Pandemic Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00478816 ↗ |
| Modality | Vaccine | “MF59-adjuvanted A/Vietnam/1194/2004 (H5N1 Clade 1) hemagglutinin (HA) subvirion influenza vaccine” NCT00478816 ↗ |
| Route | Intramuscular | “administered 3 weeks apart, IM in the deltoid muscle” NCT00478816 ↗ |